Search results
AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S.
Market Watch· 1 day agoPublished: June 12, 2024 at 6:01 p.m. ETShareResizeBy Ben GlickmanAstraZeneca's diabetes drug Farxiga on Wednesday was approved by U.S. regulators for the treatment of type-2 diabetes in children ...
AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S.
Morningstar· 1 day agoAstraZeneca's diabetes drug Farxiga on Wednesday was approved by U.S. regulators for the treatment of type-2 diabetes in children 10 and older. Farxiga, which goes by generic ...
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 24 hours agoThe US Food and Drug Administration (FDA) has granted approval for AstraZeneca's Farxiga...
Insmed retains rights to brensocatib after talks with AstraZeneca end By Investing.com
Investing.com· 18 hours agoInsmed (NASDAQ:INSM) Incorporated, a pharmaceutical company based in Bridgewater, New Jersey,...
AstraZeneca (LON:AZN) Given New £150 Price Target at Berenberg Bank
ETF DAILY NEWS· 4 days agoAstraZeneca (LON:AZN – Get Free Report) had its target price increased by equities research analysts at Berenberg Bank from £130 ($166.56) to £150 ($192.18) in a research ...
AstraZeneca champions early kidney disease diagnosis with modelling data
Pharmaceutical Technology via Yahoo Finance· 2 days agoAstraZeneca has highlighted both the economic and environmental benefits of implementing early,...
Astrazeneca (AZN) Advances But Underperforms Market: Key Facts
Zacks via Yahoo Finance· 3 days agoAstrazeneca (AZN) closed the most recent trading day at $80.21, moving +0.24% from the previous...
AstraZeneca's (AZN) Tagrisso sNDA Gets FDA's Priority Tag
Zacks via Yahoo Finance· 4 days agoThe FDA grants priority review to AstraZeneca's (AZN) Tagrisso for treating patients with...
The No-Brainer Buys: 3 Stocks That Are Absolute Must-Owns Right Now
InvestorPlace via Yahoo Finance· 7 days agoToday, we discuss three must-own stocks as major Wall Street indices reach new highs. The rise in...
Brokerage maintains buy on AstraZeneca shares, sees growth potential By Investing.com
Investing.com· 7 days agoOn Friday, TD Cowen affirmed its positive stance on AstraZeneca (NASDAQ:AZN), maintaining a Buy...